Conference
INHIBITION OF WILMS TUMOR XENOGRAFT PROGRESSION BY HALOFUGINONE IS ACCOMPANIED BY ACTIVATION OF WT-1 GENE EXPRESSION
Abstract
PURPOSE: Wilms tumor (WT) is the most common malignant neoplasm of the urinary tract in children. Although it is curable with long-term survival, the combination of surgery, chemotherapy and often radiotherapy in some cases results in severe complications in adulthood. Therefore, novel therapeutic strategies that would decrease treatment burden and improve outcome for high risk patients are required. We evaluated the efficacy of halofuginone, …
Authors
PINTHUS JH; SHEFFER Y; NAGLER A; FRIDMAN E; MOR Y; GENINA O; PINES M
Volume
174
Pagination
pp. 1527-1531
Publisher
Wolters Kluwer
Publication Date
October 2005
DOI
10.1097/01.ju.0000179218.16587.d2
Conference proceedings
Journal of Urology
Issue
4, Part 2 of 2
ISSN
0021-0005
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Angiogenesis InhibitorsAnimalsCell LineChild, PreschoolCollagenDisease ProgressionGene Expression Regulation, NeoplasticHumansIn Situ HybridizationInjections, IntraperitonealKidney NeoplasmsMiceMice, NudeNeovascularization, PathologicPiperidinesProto-Oncogene Proteins c-metQuinazolinesQuinazolinonesReceptor, ErbB-2Transplantation, HeterologousWT1 ProteinsWilms Tumor